SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin’s arm recalls Morphine Sulfate extended-release tablets in US

06 May 2019 Evaluate

Lupin’s subsidiary -- Novel Laboratories’ Somerset facility is recalling 46,700 bottles of Morphine Sulfate extended-release tablets, used to treat severe pain, in the US market. The recalling is in various strengths due to failed impurities/degradation specifications.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2499.75 -3.15 (-0.13%)
10-Jul-2026 10:02 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.00
Dr. Reddys Labs. 1239.40
Cipla 1446.90
Zydus Lifesciences 1155.10
Lupin 2499.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: